Identical to our previous study [42], we also employed BxPC3 (expressing wild-type Ki-Ras) and SU.86.86 (expressing mutated Ki-Ras) pancreatic carcinoma cells. Here, KRAS is linked to exocrine pancreatic carcinoma.